Condition: Prostate Adenocarcinoma · Sponsor: Hackensack Meridian Health
Male adults with a confirmed diagnosis of prostate adenocarcinoma who meet criteria for localized high risk prostate cancer according to the NCCN guidelines and who are eligible for prostatectomy will be invited to participate. Criteria for high-risk prostate cancer include patients with preoperative prostate biopsy score of Gleason 8 (GS8) (Grade group 4 \[GG4\]) or higher. Patients also need to have a positive PSMA scan on 68-Ga-PSMA-11 PET/CT scan.
This description comes directly from the study's public registry record.
Oncology Clinical Research Referral Office · 551-996-1777 · OncologyResearchReferral@hmhn.org
Always discuss trial participation with your own doctor first.
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| Lombardi Comprehensive Cancer Center at Georgetown University Medical Center | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| John Theurer Cancer Center at Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06798558